SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-24-000541
Filing Date
2024-01-18
Accepted
2024-01-18 17:21:23
Documents
2
Period of Report
2024-01-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1727
2 POA poa_ngrundjan24.txt EX-24 3436
  Complete submission text file 0001562180-24-000541.txt   6562
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Issuer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AMAG PHARMACEUTICALS, INC. WALTHAM MA 02451
Business Address
Grund Nicholas (Reporting) CIK: 0001661887 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36352 | Film No.: 24542816